Reduced 5-FU clearance in a patient with low DPD activity due to heterozygosity for a mutant allele of the DPYD gene

5-fluorouracil pharmacokinetics, dihydropyrimidine dehydrogenase-activity and DNA sequence analysis were compared between a patient with extreme 5-fluorouracil induced toxicity and six control patients with normal 5-fluorouracil related symptoms. Patients were treated for colorectal cancer and recei...

Descripción completa

Detalles Bibliográficos
Autores principales: Maring, J G, van Kuilenburg, A B P, Haasjes, J, Piersma, H, Groen, H J M, Uges, D R A, Van Gennip, A H, De Vries, E G E
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2002
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364178/
https://www.ncbi.nlm.nih.gov/pubmed/11953843
http://dx.doi.org/10.1038/sj.bjc.6600208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364178/
https://www.ncbi.nlm.nih.gov/pubmed/11953843
http://dx.doi.org/10.1038/sj.bjc.6600208

Ejemplares similares